lumbosacral spinal stenosis. SPINAL STENOSIS ,LUMBAR REGION
Conditions
Interventions
Intervention 1: control group:80 mg methyl prednisolon and 4 cc marcaine epidural injection plus education of life style modification and exercise. Intervention 2: intervention group:80 mg methyl pred
Treatment - Drugs
control group:80 mg methyl prednisolon and 4 cc marcaine epidural injection plus education of life style modification and exercise
intervention group:80 mg methyl prednisolon , 4 cc marcaine and 100 units calcitonin epidural injection plus education of life style modification and exercise
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
45 Years to 75 Years
Inclusion criteria
Inclusion criteria: Lumbar pain nonresponsive to conservative management for 6 months Between 45-75 y/o Completing and signing informed consent form
Exclusion criteria
Exclusion criteria: Diabetes Mellitus Rhematoid arthritis,collagen vascular disease,gout, lupus Simultaneous lumbar radiculopathy or neuropathy Bruclla infection BMI>42 Knee or hip arthroplasty Bleeding tendencies and disorders Impaired cognition Drug allergy Liver,renal,pulmonary or cardiac problem Pregnancy Cancer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: 2 months. Method of measurement: VAS,OSWESTRY,Quebec questionnaires. | — |
Secondary
| Measure | Time frame |
|---|---|
| Functional class and quality of life improvement,decreased oral medication consumption. Timepoint: 2 months. Method of measurement: VAS,OSWESTRY,QUEBEC questionnaires. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamid Reza Farpour
Shiraz University of Medical Sciences
Outcome results
None listed